BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 25696892)

  • 1. Thrombotic microangiopathy and indications for therapeutic plasma exchange.
    Adamski J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):444-9. PubMed ID: 25696892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group].
    Contreras E; de la Rubia J; Del Río-Garma J; Díaz-Ricart M; García-Gala JM; Lozano M;
    Med Clin (Barc); 2015 Apr; 144(7):331.e1-331.e13. PubMed ID: 25433791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Thrombotic Microangiopathy: A Review.
    Genest DS; Patriquin CJ; Licht C; John R; Reich HN
    Am J Kidney Dis; 2023 May; 81(5):591-605. PubMed ID: 36509342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of microangiopathic hemolytic anemia].
    Morishita E
    Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic Microangiopathy Syndrome in a Basic Underwater Demolition/SEAL Student.
    Croom D; Tracy H
    J Spec Oper Med; 2016; 16(3):16-19. PubMed ID: 27734437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic Microangiopathy: A Multidisciplinary Team Approach.
    Gordon CE; Chitalia VC; Sloan JM; Salant DJ; Coleman DL; Quillen K; Ravid K; Francis JM
    Am J Kidney Dis; 2017 Nov; 70(5):715-721. PubMed ID: 28720207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HUS and TTP: traversing the disease and the age spectrum.
    Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
    Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathy in children.
    Palma LMP; Vaisbich-Guimarães MH; Sridharan M; Tran CL; Sethi S
    Pediatr Nephrol; 2022 Sep; 37(9):1967-1980. PubMed ID: 35041041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathies: from animal models to human disease and cure.
    Caprioli J; Remuzzi G; Noris M
    Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies: Lessons learned from a 14-year retrospective study.
    Tau J; Fernando LP; Munoz MC; Poh C; Krishnan VV; Dwyre DM
    Ther Apher Dial; 2023 Feb; 27(1):136-145. PubMed ID: 35501999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus disease 2019-associated thrombotic microangiopathy treated with plasma exchange and antihypertensive therapy in a patient with HIV: A case report with literature review.
    Masuda E; Fukushima K; Hebisawa Y; Tanaka M; Ohta A; Imamura A
    Medicine (Baltimore); 2023 Oct; 102(41):e35469. PubMed ID: 37832064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.